1
|
Woelber L, Bommert M, Harter P, Prieske K, zu Eulenburg C, Jueckstock J, Hilpert F, de Gregorio N, Iborra S, Sehouli J, Ignatov A, Hillemanns P, Fuerst S, Strauss HG, Baumann K, Thiel F, Mustea A, Meier W, Wimberger P, Hanker L, Schmalfeldt B, Canzler U, Fehm T, Luyten A, Hellriegel M, Kosse J, Heiss C, Hantschmann P, Mallmann P, Tanner B, Pfisterer J, Mahner S, Jaeger A. Role of pelvic lymph node resection in vulvar cancer – a subset analysis of the AGO-CaRE-1 study. Geburtshilfe Frauenheilkd 2020. [DOI: 10.1055/s-0040-1717203] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
Affiliation(s)
- L Woelber
- Department of Gynecology and Gynecologic Oncology, University Medical Center Hamburg-Eppendorf
| | | | | | - K Prieske
- Department of Gynecology and Gynecologic Oncology, University Medical Center Hamburg-Eppendorf
| | - C zu Eulenburg
- Department of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf
| | - J Jueckstock
- Department of Gynecology and Obstetrics, University of Munich
| | - F Hilpert
- Oncologic Medical Center at the Jerusalem Hospital Hamburg
| | - N de Gregorio
- Department of Obstetrics and Gynecology, University of Ulm Medical Center
| | - S Iborra
- Gynecology and Gynecologic Oncology, University Hospital Freiburg
| | - J Sehouli
- Department of Gynecology, Charité University Medicine Berlin, Campus Virchow
| | - A Ignatov
- Department of Obstetrics and Gynecology, University Hospital Magdeburg
| | - P Hillemanns
- Department of Obstetrics and Gynecology, Hannover Medical School
| | - S Fuerst
- Department of Gynecology and Obstetrics, University of Munich
| | - HG Strauss
- Department of Gynecology, University Hospital Halle
| | - K Baumann
- Department of Gynecology, Medical Center Ludwigshafen
| | - F Thiel
- Department of Gynecology, Medical Center am Eichert, Alb Fils Clinic, Klinik am Eichert
| | - A Mustea
- Department of Gynecology and Gynecologic Oncology, University Medical Center Bonn
| | - W Meier
- Department of Obstetrics and Gynecology, Evangelical Hospital Duesseldorf
| | - P Wimberger
- Department of Gynecology and Gynecologic Oncology, Technical University Medical Center Dresden
| | - L Hanker
- Department of Gynecology and Gynecologic Oncology, University Medical Center Luebeck
| | - B Schmalfeldt
- Department of Gynecology and Gynecologic Oncology, University Medical Center Hamburg-Eppendorf
| | - U Canzler
- Department of Gynecology and Gynecologic Oncology, Technical University Medical Center Dresden
| | - T Fehm
- Department of Obstetrics and Gynecology, Evangelical Hospital Duesseldorf
| | - A Luyten
- Department of Gynecology and Obstetrics, Medical Center Wolfsburg
| | - M Hellriegel
- Department of Gynecology and Gynecologic Oncology, University Medical Center Goettingen
| | - J Kosse
- Department of Gynecology and Obstetrics, Medical Center Offenbach
| | - C Heiss
- Department of Gynecology, Medical Center am Eichert, Alb Fils Clinic, Klinik am Eichert
| | - P Hantschmann
- Department of Gynecology and Obstetrics, Medical Center Altoetting
| | - P Mallmann
- Department of Gynecology and Gynecologic Oncology, University Medical Center Koeln
| | - B Tanner
- Department of Gynecology and Obstetrics, Medical Center Oranienburg
| | - J Pfisterer
- Department of Gynecology and Gynecologic Oncology, University Medical Center Kiel
| | - S Mahner
- Department of Gynecology and Obstetrics, University of Munich
| | - A Jaeger
- Department of Gynecology and Gynecologic Oncology, University Medical Center Hamburg-Eppendorf
| |
Collapse
|
2
|
Prieske K, Woelber L, Muallem M, Eulenburg C, Jückstock J, Hilpert F, de Gregorio N, Iborra S, Ignatov A, Hillemanns P, Fuerst S, Strauss H, Baumann K, Thiel F, Mustea A, Meier W, Harter P, Wimberger P, Hanker L, Schmalfeldt B, Canzler U, Fehm T, Luyten A, Hellriegel M, Kosse J, Heiss C, Hantschmann P, Mallmann P, Tanner B, Pfisterer J, Sehouli J, Mahner S. The influence of age on treatment and prognosis of patients with squamous cell vulvar cancer (VSCC)- a subset analysis of the AGO-CaRE-1 study. Geburtshilfe Frauenheilkd 2020. [DOI: 10.1055/s-0040-1718171] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
Affiliation(s)
- K Prieske
- Universitätklinikum Hamburg-Eppendorf, Klinik und Poliklinik für Gynäkologie
| | - L Woelber
- Universitätklinikum Hamburg-Eppendorf, Klinik und Poliklinik für Gynäkologie
| | - M.Z Muallem
- Charité, Campus Virchow Klinikum, Frauenklinik
| | - C Eulenburg
- Universitätklinikum Hamburg-Eppendorf, Institut für medizinische Biometrie und Epidemiologie
| | - J Jückstock
- Klinikum der Ludwig-Maximilians-Universität München, Campus Großhadern& Campus Innenstadt, Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe
| | - F Hilpert
- Onkologisches Therapiezentrum am Jerusalem Krankenhaus
| | | | - S Iborra
- Uniklinik RWTH Aachen, Klinik für Gynäkologie und Geburtsmedizin
- Universitätsklinikum Freiburg, Universitäts- Frauenklinik
| | - A Ignatov
- Universitätsklinikum Magdeburg, Frauenklinik
| | | | - S.T Fuerst
- Klinikum der Ludwig-Maximilians-Universität München, Campus Großhadern& Campus Innenstadt, Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe
| | - H.G Strauss
- Universitätsklinikum Martin-Luther-Universität Halle-Wittenberg
| | | | - F Thiel
- Alb Fils Kliniken, Klinik am Eichert, Frauenklinik
| | - A Mustea
- Universitätsklinikum Bonn, Klinik für Gynäkologie und Gynäkologische Onkologie
| | - W Meier
- Evangelisches Krankenhaus, Frauenklinik
| | - P Harter
- Kliniken Essen-Mitte (KEM) Evang. Huyssens-Stiftung/Knappschaft GmbH, Klinik für Gynäkologie und gynäkologische Onkologie
| | - P Wimberger
- Technische Universität Dresden, Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe
| | - L Hanker
- Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Klinik für Frauenheilkunde und Geburtshilfe
| | - B Schmalfeldt
- Universitätklinikum Hamburg-Eppendorf, Klinik und Poliklinik für Gynäkologie
| | - U Canzler
- Technische Universität Dresden, Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe
| | - T Fehm
- Universitätsklinikum Düsseldorf, Universitätsfrauenklinik
| | - A Luyten
- Klinikum Wolfsburg, Frauenklinik
- Dysplasie-Einheit an der Park-Klinik Kiel
| | - M Hellriegel
- Georg-August-Universitätsklinikum Göttingen, Universitäts-Frauenklinik
| | - J Kosse
- Sana Klinikum Offenbach, Frauenklinik
| | - C Heiss
- Alb Fils Kliniken, Klinik am Eichert, Frauenklinik
| | | | - P Mallmann
- Klinikum der Universität zu Köln, Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe
| | - B Tanner
- Oberhavel Kliniken, Klinik Oranienburg, Frauenklinik
| | | | - J Sehouli
- Charité, Campus Virchow Klinikum, Frauenklinik
| | - S Mahner
- Klinikum der Ludwig-Maximilians-Universität München, Campus Großhadern& Campus Innenstadt, Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe
| |
Collapse
|
3
|
Jueckstock J, Fuerst S, Bommert M, Harter P, Prieske K, Eulenburg C, Hilpert F, deGregorio N, Iborra S, Sehouli J, Ignatov A, Hillemanns P, Jaeger A, Strauss HG, Baumann K, Thiel F, Mustea A, Meier W, Wimberger P, Hanker L, Schmalfeldt B, Canzler U, Fehm T, Luyten A, Hellriegel M, Kosse J, Heiss C, Hantschmann P, Mallmann P, Tanner B, Pfisterer J, Woelber L, Mahner S. Bedeutung der pelvinen Lymphonodektomie beim Plattenepithelkarzinom der Vulva (VSCC) – Subgruppenanalyse der AGO-CaRE-1 Studie. Geburtshilfe Frauenheilkd 2020. [DOI: 10.1055/s-0040-1713981] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
Affiliation(s)
- J Jueckstock
- Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, Klinikum der Universität München, LMU München
| | - S Fuerst
- Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, Klinikum der Universität München, LMU München
| | - M Bommert
- Klinik für Gynäkologie & Gynäkologische Onkologie, Evang. Kliniken Essen-Mitte, Essen
| | - P Harter
- Klinik für Gynäkologie & Gynäkologische Onkologie, Evang. Kliniken Essen-Mitte, Essen
| | - K Prieske
- Klinik und Poliklinik für Gynäkologie, Universitätsklinikum Hamburg-Eppendorf, Hamburg
| | - C Eulenburg
- Institut für Medizinische Biometrie und Epidemiologie, Universitätsklinikum Hamburg-Eppendorf, Hamburg
| | - F Hilpert
- Onkologisches Kompetenzzentrum, Krankenhaus Jerusalem, Hamburg
| | - N deGregorio
- Klinik für Frauenheilkunde und Geburtshilfe, Universitätsklinikum Ulm
| | - S Iborra
- Klinik für Gynäkologie und Geburtsmedizin, Uniklinik RWTH Aachen
| | - J Sehouli
- Klinik für Gynäkologie, Charité Universitätsmedizin Berlin, Campus Virchow-Klinikum, Berlin
| | - A Ignatov
- Universitätsklinik für Frauenheilkunde, Geburtshilfe und Reproduktionsmedizin, Magdeburg
| | - P Hillemanns
- Klinik für Frauenheilkunde und Geburtshilfe, Medizinische Hochschule Hannover
| | - A Jaeger
- Klinik und Poliklinik für Gynäkologie, Universitätsklinikum Hamburg-Eppendorf, Hamburg
| | - H-G Strauss
- Universitätsklinik und Poliklinik für Gynäkologie, Halle
| | - K Baumann
- Frauenklinik am Klinikum Ludwigshafen
| | - F Thiel
- Frauenklinik mit Gynäkologie und Geburtshilfe, Alb Fils Kliniken, Klinik am Eichert, Göppingen
| | - A Mustea
- Zentrum für Geburtshilfe und Frauenheilkunde, Universitätsklinikum Bonn
| | - W Meier
- Klinik für Frauenheilkunde und Geburtshilfe, Universitätsklinikum Düsseldorf
| | - P Wimberger
- Klinik für Frauenheilkunde und Geburtshilfe, Universitätsklinikum, Technische Universität Dresden
| | - L Hanker
- Klinik für Frauenheilkunde und Geburtshilfe, Universitätsklinikum Schleswig-Holstein, Campus Lübeck
| | - B Schmalfeldt
- Klinik und Poliklinik für Gynäkologie, Universitätsklinikum Hamburg-Eppendorf, Hamburg
| | - U Canzler
- Klinik für Frauenheilkunde und Geburtshilfe, Universitätsklinikum, Technische Universität Dresden
| | - T Fehm
- Klinik für Frauenheilkunde und Geburtshilfe, Universitätsklinikum Düsseldorf
| | - A Luyten
- Frauenklinik, Klinikum Wolfsburg
| | - M Hellriegel
- Klinik für Gynäkologie und Geburtshilfe, Universitätsmedizin Göttingen
| | - J Kosse
- Klinik für Gynäkologie und Geburtshilfe, Sana Klinikum Offenbach
| | - C Heiss
- Frauenklinik mit Gynäkologie und Geburtshilfe, Alb Fils Kliniken, Klinik am Eichert, Göppingen
| | - P Hantschmann
- Klinik für Gynäkologie und Geburtshilfe, Kreiskliniken Altötting-Burghausen, Altötting
| | - P Mallmann
- Klinik für Frauenheilkunde und Geburtshilfe, Uniklinik Köln
| | - B Tanner
- Klinik für Gynäkologie und Geburtshilfe, Oberhavel Klinik Oranienburg
| | | | - L Woelber
- Klinik und Poliklinik für Gynäkologie, Universitätsklinikum Hamburg-Eppendorf, Hamburg
| | - S Mahner
- Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, Klinikum der Universität München, LMU München
| |
Collapse
|
4
|
Petry KU, Horn J, Luyten A, Mikolajczyk RT. Punch biopsies shorten time to clearance of high-risk human papillomavirus infections of the uterine cervix. BMC Cancer 2018; 18:318. [PMID: 29566658 PMCID: PMC5865384 DOI: 10.1186/s12885-018-4225-9] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/17/2017] [Accepted: 03/14/2018] [Indexed: 11/10/2022] Open
Abstract
Background The primary objective was to determine human papilloma virus (HPV) clearance rate after cervical biopsy among women with persistent high-risk HPV infection compared with spontaneous HPV clearance rate in the absence of biopsy. Methods We collected data from a dedicated screening program of women aged 30–70 years old. Inclusion criteria for the baseline non-interventional cohort were a positive HPV test (hybrid capture 2, HC2) and normal cytology. In the baseline cohort women were followed with approximately yearly HPV-tests and cytology until HPV regressed (one negative HPV test) or interventions in the form of diagnostic biopsies or therapy. Women who had a diagnostic biopsy were included in the biopsy cohort and followed until HPV regression or therapy. Observed HPV regression rates and time to HPV regression were compared between baseline and biopsy cohorts. For the comparison, we used Fisher’s exact test for the HPV regression rates and interval-censored, accelerated failure time model for time to HPV regression. Results Among the 1079 women included in the baseline cohort, 499 (46.3%) had HPV clearance and 475 were referred for colposcopy with biopsy. The biopsy cohort comprised all women who were not treated and had at least one HC2 test after biopsy (201/475; 42.3%). Of those, 138 (68.7%) experienced HPV regression. In the biopsy cohort, time to clearance of HPV infection was approximately halved (0.46, 95% CI 0.38–0.56) compared with the baseline cohort. This result was robust in a wide range of sensitivity analyses. Conclusions A higher proportion of women cleared their HPV infection, and time to HPV clearance was shorter in the biopsy cohort than in the baseline cohort. It is reassuring for clinicians to know that conservative management of patients with HPV persistency is successful when colposcopy with biopsies excludes high-grade disease.
Collapse
Affiliation(s)
- K U Petry
- Department of Obstetrics and Gynecology, Klinikum Wolfsburg, Wolfsburg, Germany.
| | - J Horn
- Institute for Medical Epidemiology, Biometrics, and Informatics, Martin-Luther-University Halle-Wittenberg, Halle, Germany
| | - A Luyten
- Department of Obstetrics and Gynecology, Klinikum Wolfsburg, Wolfsburg, Germany
| | - R T Mikolajczyk
- Institute for Medical Epidemiology, Biometrics, and Informatics, Martin-Luther-University Halle-Wittenberg, Halle, Germany.,Hannover Medical School, Hannover, Germany.,German Centre for Infection Research/ Site Braunschweig-Hannover, Braunschweig, Germany
| |
Collapse
|
5
|
Luyten A, Strehlke S, Weiß V, Iftner A, Iftner T, Petry KU. WOLVES – impact of HPV vaccination in Wolfsburg, Germany. Geburtshilfe Frauenheilkd 2016. [DOI: 10.1055/s-0036-1592699] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
6
|
Luyten A, Mikolajczyk RT, Horn J, Petry KU. Accelerated regression rates of cervical high-risk human papillomavirus infections by punch biopsies of the uterine cervix. Geburtshilfe Frauenheilkd 2016. [DOI: 10.1055/s-0036-1592723] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
7
|
Luyten A, Strehlke S, Iftner A, Iftner T, Petry KU. HPV clearance and persistency in young women – five years follow of WOLVES- study. Geburtshilfe Frauenheilkd 2016. [DOI: 10.1055/s-0036-1593022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
8
|
Klapdor R, Wölber L, Jückstock J, Hillemanns P, Hilpert F, de Gregorio N, Iborra S, Sehouli J, Habermann A, Fürst ST, Strauß HG, Baumann K, Thiel F, Mustea A, Meier W, Harter P, Wimberger P, Hanker L, Schmalfeldt B, Canzler U, Fehm T, Luyten A, Hellriegel M, Kosse J, Heiss C, Hantschmann P, Mallmann P, Tanner B, Pfisterer J, Richter B, Jäger M, Mahner S. Sentinellymphonodektomie beim Vulvakarzinom: Eine Subgruppenanalye der AGO-CaRE-1 Multicenterstudie. Geburtshilfe Frauenheilkd 2016. [DOI: 10.1055/s-0036-1593256] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
9
|
Luyten A, Strehlke S, Rothe B, Petry KU. Comparison of Anyplex II HPV HR- and Hybrid Capture2 testing in a screening population (WOLPHSCREEN). Geburtshilfe Frauenheilkd 2016. [DOI: 10.1055/s-0036-1592686] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
10
|
Wölber L, Jückstock J, Neuser P, Hilpert F, de Gregorio N, Iborra S, Sehouli J, Habermann A, Hillemanns P, Fürst S, Strauss HG, Baumann K, Thiel F, Mustea A, Meier W, Harter P, Wimberger P, Hanker L, Schmalfeldt B, Canzler U, Fehm T, Luyten A, Hellrigel M, Kosse J, Heiss C, Hantschmann P, Mallmann P, Tanner B, Pfisterer J, Richter B, Eulenburg C, Mahner S. Prognose nach isoliertem Lokalrezidiv beim Vulvakarzinom – eine Subgruppenanalyse der AGO-CaRE-1 Studie. Geburtshilfe Frauenheilkd 2016. [DOI: 10.1055/s-0036-1592661] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
11
|
Luyten A, Bettens K, D'haeseleer E, Hodges A, Galiwango G, Vermeersch H, Van Lierde K. Short-term effect of short, intensive speech therapy on articulation and resonance in Ugandan patients with cleft (lip and) palate. J Commun Disord 2016; 61:71-82. [PMID: 27060419 DOI: 10.1016/j.jcomdis.2016.03.006] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/03/2015] [Revised: 11/24/2015] [Accepted: 03/26/2016] [Indexed: 06/05/2023]
Abstract
OBJECTIVES The purpose of the current study was to assess the short-term effectiveness of short and intensive speech therapy provided to patients with cleft (lip and) palate (C(L)P) in terms of articulation and resonance. METHODS Five Ugandan patients (age: 7.3-19.6 years) with non-syndromic C(L)P received six hours of individualized speech therapy in three to four days. Speech therapy focused on correct phonetic placement and contrasts between oral and nasal airflow and resonance. Speech evaluations performed before and immediately after speech therapy, including perceptual and instrumental assessment techniques, were compared. RESULTS Post-therapy, improvement of speech was noted for most of the patients, although to varying degrees. Clinically relevant progress of objective nasalance values and/or articulation was obtained in four patients. Overall, two patients showed normal speech intelligibility, while three patients required additional speech therapy. CONCLUSION These preliminary short-term results demonstrate that short and intensive speech therapy can be effective for patients with C(L)P in countries with limited access to speech-language therapy. However, further research is needed on the long-term effectiveness and the advantages of applying this treatment protocol in countries with good access to speech therapy. LEARNING OUTCOMES The reader will be able to (1) list the challenges in resource poor-countries to achieve access to speech-language therapy services, (2) describe when the application of speech therapy is appropriate in patients with C(L)P, (3) describe the speech therapy that can be applied to reduce compensatory articulation and resonance disorders in patients with C(L)P, and (4) list the (possible) advantages of short, intensive speech therapy for both resource-poor and developed countries.
Collapse
Affiliation(s)
- A Luyten
- Ghent University, Department of Speech, Language, and Hearing Sciences, De Pintelaan 185 2P1, 9000 Gent, Belgium.
| | - K Bettens
- Ghent University, Department of Speech, Language, and Hearing Sciences, De Pintelaan 185 2P1, 9000 Gent, Belgium.
| | - E D'haeseleer
- Ghent University, Department of Speech, Language, and Hearing Sciences, De Pintelaan 185 2P1, 9000 Gent, Belgium.
| | - A Hodges
- Comprehensive Rehabilitation Services in Uganda (CoRSU), P.O. Box 46, Kisubi, Uganda.
| | - G Galiwango
- Comprehensive Rehabilitation Services in Uganda (CoRSU), P.O. Box 46, Kisubi, Uganda.
| | - H Vermeersch
- Ghent University, Department of Head and Neck Surgery, De Pintelaan 185 2P2, 9000 Gent, Belgium.
| | - K Van Lierde
- Ghent University, Department of Speech, Language, and Hearing Sciences, De Pintelaan 185 2P1, 9000 Gent, Belgium.
| |
Collapse
|
12
|
Luyten A, Petry KU. Relevance of HPV Screening for Triaging Equivocal Cytology Findings in the Pap II-p, Pap III and Pap IIID Groups - Results of Two Long-Term Studies. Geburtshilfe Frauenheilkd 2015; 75:1058-1062. [PMID: 26556908 DOI: 10.1055/s-0035-1557841] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
Abstract
Introduction: The use of HPV screening for the triage of ASC-US (atypical squamous cells of undetermined significance) cytology results has been established as a sound standard by international trials whereas the data for other cytology findings are in part contradictory. There is a lack of long-term studies on the use of HPV triage in Germany. Materials and Methods: For the present study data from a primary HPV screening project involving women aged over 30 years, ongoing since 2006, and an epidemiological study on women aged between 20 and 27 years, ongoing since 2009, were used. Upon recruitment, all women underwent a smear test for cytology and screening for "high-risk" HPV using Hybrid Capture 2 (HC2). If both tests were positive or if there were persisting remarkable cytology findings or a positive HPV test, then clarification by colposcopy was performed. Results: Altogether, among 282 women with Pap II-p (ASC-US), Pap III (ASC-H) or Pap IIID (LSIL + CIN2) and negative HPV test there was no case of CIN3+. Among the women under 30 years of age, however, 69 % (ASC-US) to 85 % (LSIL + CIN2) of the remarkable findings were HPV positive, also among the older women with Pap IIID, the 71 % prevalence of HPV was too high for a triage and even without triage there was a 23 % risk for CIN3+. On the other hand, of the women over 30 years old with ASC-US (Pap II-p) findings, only 21 % were positive for HPV and the risk for CIN3+ in this group was high at 29 %. Also for ASC-H (Pap III) findings in the age group of over 30 years with an HPV prevalence of 56 % there was an efficient triage for CIN3+. Discussion: In summary, the HPV triage of ASC-US (Pap II-p) findings in women aged over 30 years was found to be efficient; in contrast, LSIL + CIN2 (Pap IIID) findings in this age group justified an immediate referral to colposcopy whereas cytology control appeared to be sufficient for younger women.
Collapse
Affiliation(s)
- A Luyten
- Frauenklinik im Klinikum Wolfsburg, Wolfsburg
| | - K U Petry
- Frauenklinik im Klinikum Wolfsburg, Wolfsburg
| |
Collapse
|
13
|
Van Lierde KM, Luyten A, D'haeseleer E, Van Maele G, Becue L, Fonteyne E, Corthals P, De Pauw G. Articulation and oromyofunctional behavior in children seeking orthodontic treatment. Oral Dis 2015; 21:483-92. [PMID: 25537125 DOI: 10.1111/odi.12307] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/04/2014] [Revised: 11/26/2014] [Accepted: 12/12/2014] [Indexed: 11/28/2022]
Affiliation(s)
- KM Van Lierde
- Department of Speech, Language and Hearing Sciences; Ghent University; Gent Belgium
| | - A Luyten
- Department of Speech, Language and Hearing Sciences; Ghent University; Gent Belgium
| | - E D'haeseleer
- Department of Speech, Language and Hearing Sciences; Ghent University; Gent Belgium
| | - G Van Maele
- Department of Biostatistics; Ghent University; Gent Belgium
| | - L Becue
- Department of Speech, Language and Hearing Sciences; Ghent University; Gent Belgium
| | - E Fonteyne
- Department of Speech, Language and Hearing Sciences; Ghent University; Gent Belgium
| | - P Corthals
- Department of Speech, Language and Hearing Sciences; University College Ghent; Ghent University & Faculty of Education, Health and Social Work; Gent Belgium
| | - G De Pauw
- Department of Orthodontics; Ghent University; Gent Belgium
| |
Collapse
|
14
|
Luyten A, Strehlke S, Luyten K, Iftner A, Iftner T, Petry KU. WOLVES – Genotypenspezifisches Modell der HPV-Clearance und -Persistenz bei jungen Frauen in Wolfsburg. Geburtshilfe Frauenheilkd 2014. [DOI: 10.1055/s-0034-1388374] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
|
15
|
Luyten A, Hastor H, Luyten K, Petry KU. Detektionen nicht-zervikaler Dysplasien und Karzinome im Rahmen eines primären HPV Screenings. Geburtshilfe Frauenheilkd 2014. [DOI: 10.1055/s-0034-1388563] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
|
16
|
Woelber L, Kosse J, Heiss C, Neuser P, Hantschmann P, Mallmann P, Tanner B, Pfisterer J, Richter B, Jückstock J, Hilpert F, De Gregorio N, Iborra S, Sehouli J, Habermann A, Hillemanns P, Fürst S, Strauss HG, Baumann K, Thiel F, Mustea A, Meier W, Harter P, Wimberger P, Hanker L, Schmalfeldt B, Canzler U, Fehm T, Luyten A, Hellriegel M, Mahner S. Lokaler Resektionsrand und Rezidivrisiko beim Plattenepithelkarzinom der Vulva – Ergebnisse einer Subgruppenanalyse der multizentrischen AGO CaRE-1 Studie. Geburtshilfe Frauenheilkd 2014. [DOI: 10.1055/s-0034-1388596] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
|
17
|
Luyten A, Luyten K, Strehlke S, Petry KU. WOLPHSCREEN – Klinischer Verlauf neu erworbener HPV-Infektionen bei Frauen ab 35 Jahren. Geburtshilfe Frauenheilkd 2014. [DOI: 10.1055/s-0034-1388341] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
|
18
|
Lambaerts K, Van Dyck S, Mortier E, Ivarsson Y, Degeest G, Luyten A, Vermeiren E, Peers B, David G, Zimmermann P. Syntenin, a syndecan adaptor and an Arf6 phosphatidylinositol 4,5-bisphosphate effector, is essential for epiboly and gastrulation cell movements in zebrafish. Development 2012. [DOI: 10.1242/dev.082610] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
|
19
|
Luyten A, Dhaeseleer E, Hodges A, Galiwango G, Budolfsen T, Vermeersch H, Van Lierde K. Normative Nasalance Data in Ugandan English-Speaking Children. Folia Phoniatr Logop 2012; 64:131-6. [DOI: 10.1159/000338235] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open
|
20
|
Van Lierde K, Galiwango G, Hodges A, Bettens K, Luyten A, Vermeersch H. Impact of tongue reduction on overall speech intelligibility, articulation and oromyofunctional behavior in 4 children with Beckwith-Wiedemann syndrome. Folia Phoniatr Logop 2011; 64:55-63. [PMID: 22095257 DOI: 10.1159/000329569] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open
Abstract
OBJECTIVE The purpose of this study was to determine the impact of partial glossectomy (using the keyhole technique) on speech intelligibility, articulation, resonance and oromyofunctional behavior. PATIENTS AND METHODS A partial glossectomy was performed in 4 children with Beckwith- Wiedemann syndrome between the ages of 0.5 and 3.1 years. An ENT assessment, a phonetic inventory, a phonemic and phonological analysis and a consensus perceptual evaluation of speech intelligibility, resonance and oromyofunctional behavior were performed. RESULTS It was not possible in this study to separate the effects of the surgery from the typical developmental progress of speech sound mastery. Improved speech intelligibility, a more complete phonetic inventory, an increase in phonological skills, normal resonance and increased motor-oriented oral behavior were found in the postsurgical condition. The presence of phonetic distortions, lip incompetence and interdental tongue position were still present in the postsurgical condition. CONCLUSION Speech therapy should be focused on correct phonetic placement and a motor-oriented approach to increase lip competence, and on functional tongue exercises and tongue lifting during the production of alveolars. Detailed analyses in a larger number of subjects with and without Beckwith-Wiedemann syndrome may help further illustrate the long-term impact of partial glossectomy.
Collapse
Affiliation(s)
- K Van Lierde
- Department of ENT, Head and Neck Surgery and Logopaedics, University Hospital Gent, Gent , Belgium.
| | | | | | | | | | | |
Collapse
|
21
|
Laksana A, Luyten A, Sogari A, Pietralla M, Petry K. Onkologie. Das Wolfsburger Pilotprojekt zur Risiko-adaptierten Prävention des Zervixkarzinoms. Geburtshilfe Frauenheilkd 2011. [DOI: 10.1055/s-0030-1271169] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
|
22
|
Luyten A, Scherbring S, Petry K. Onkologie. Patientinnen befürworten die Durchführung der Schlingenkonisation in Lokalanästhesie zur Behandlung von CIN2/3. Geburtshilfe Frauenheilkd 2011. [DOI: 10.1055/s-0030-1270879] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
|
23
|
Van Lierde K, Luyten A, Van Borsel J, Baudonck N, Debusschere T, Vermeersch H, Bonte K. Speech intelligibility of children with unilateral cleft lip and palate (Dutch cleft) following a one-stage Wardill–Kilner palatoplasty, as judged by their parents. Int J Oral Maxillofac Surg 2010; 39:641-6. [DOI: 10.1016/j.ijom.2010.02.025] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/07/2008] [Revised: 07/03/2009] [Accepted: 02/01/2010] [Indexed: 11/16/2022]
|
24
|
Luyten A, Theiler KG, Pietralla M, Braun BE, Reinecke-Lüthge A, Petry K. Risikoadaptierte Prävention des Zervixkarzinoms. Das Wolfsburger Vorsorge-Projekt nach 18 Monaten. Geburtshilfe Frauenheilkd 2008. [DOI: 10.1055/s-2008-1038389] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
|
25
|
Luyten A, Brummer O, Kühnle H, Kreipe H, Reinecke-Lüthge A, Petry K. Neue Optionen bei der Therapie des Morbus Paget der Vulva. Geburtshilfe Frauenheilkd 2006. [DOI: 10.1055/s-2006-924608] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
26
|
Van de Werf F, Cannon CP, Luyten A, Houbracken K, McCabe CH, Berioli S, Bluhmki E, Sarelin H, Wang-Clow F, Fox NL, Braunwald E. Safety assessment of single-bolus administration of TNK tissue-plasminogen activator in acute myocardial infarction: the ASSENT-1 trial. The ASSENT-1 Investigators. Am Heart J 1999; 137:786-91. [PMID: 10220625 DOI: 10.1016/s0002-8703(99)70400-x] [Citation(s) in RCA: 113] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Abstract
BACKGROUND To evaluate the safety of several doses of a new thrombolytic, TNK tissue-plasminogen activator (tPA), given as a single bolus to patients with acute myocardial infarction. METHODS AND RESULTS A total of 3235 patients were given TNK-tPA: 1705 received 30 mg, 1457 received 40 mg, and 73 received 50 mg. The 50-mg dose was discontinued and replaced by 40 mg because of increased bleeding observed in the Thrombolysis In Myocardial Infarction (TIMI)-10B study, the phase II angiographic efficacy trial conducted in parallel with this study. The total stroke rate at 30 days in the trial was 1.5%. An intracranial hemorrhage was observed in 25 patients (0.77%): 16 in the 30-mg group (0.94%) and 9 in the 40-mg group (0.62%). No strokes occurred in the 73 patients treated with 50 mg TNK-tPA. In patients treated within 6 hours after symptom onset the rates of intracranial hemorrhage were 0.56% (30 mg TNK-tPA) and 0.58 (40 mg TNK-tPA). Death, death or nonfatal stroke, or severe bleeding complications occurred in a low proportion of patients: 6.4%, 7.4%, and 2.8%, respectively, without significant differences among the treatment groups. CONCLUSIONS The overall safety profile of a single bolus of 30 to 50 mg TNK-tPA is comparable to that of accelerated r-tPA observed in other large trials. The safety data from this trial and the patency data of TIMI-10B were the basis for a decision to conduct a large phase III mortality trial comparing weight-adjusted single-bolus TNK-tPA with accelerated r-tPA (ASSENT-2).
Collapse
Affiliation(s)
- F Van de Werf
- Department of Cardiology, Gasthuisberg University Hospital, Leuven, Belgium.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|